Search Results for "Fluconazole Pulmonary Delivery"
Original Source: Inhalable Microparticles as Carriers for Pulmonary Delivery of Thymopentin-Loaded Solid Lipid Nanoparticles.
PURPOSE: Microparticles containing solid lipid nanoparticles (SLNs) are receiving increased attention as carriers for the lung delivery of the SLNs. Thus, we aim to prepare the hybrid microparticles and thoroughly evaluate their feasibility for the pulmonary drug delivery. METHODS: The microparticles were prepared by co-spray-drying the thymopentin (TP5)-loaded SLNs with bulking agents. Thereafter, we systematically estimated the potential of the microparticles as the carriers for the pulmonary delivery of...
Matching Channels
Matching News
Polymers for pulmonary drug delivery book released by Smithers Rapra
Pulmonary drug delivery has been a rapidly expanding field, moving from the traditional propellant based metered dose inhaler delivery of small asthma drugs, to a broader landscape of new devices and...
Type: Original PaperThe controlled release of diflunisal and fluconazole from tablets made of novel polymers, poly(acrylic acid) (PAA) crosslinked with either β-cyclodextrin (βCD) or hydroxypropyl-Î...
Vaccine Delivery By Inhilation Instead Of By Injection?
In addition to the obvious benefit of eliminating the need for an injection, new vaccine delivery methods via the lungs offer particular advantages for protecting against infectious agents that enter...
Can vaccines be delivered via the lungs instead of by injection?
In addition to the obvious benefit of eliminating the need for an injection, new vaccine delivery methods via the lungs offer particular advantages for protecting against infectious agents that enter...
Miocardin in Pulmonary arterial hypertension
So, what is pulmonary hypertension (PH) is an increase in blood pressure in the pulmonary artery, pulmonary vein, or pulmonary [...]
Data support flucytosine in HIV-associated meningitis
Initial combination therapy with amphotericin B and flucytosine is associated with fewer deaths among patients with HIV-associated cryptococcal meningitis compared with amphotericin B alone (New Engl...
CPF and PFF to partner with ATS to fund pulmonary fibrosis research
The Coalition for Pulmonary Fibrosis, the Pulmonary Fibrosis Foundation, and the American Thoracic Society-the world's leading professional organization for pulmonary, critical care and sleep medicine...
Pharmaceutical Research: Nanocarriers Targeting Dendritic Cells for Pulmonary Vaccine Delivery
Type: Review PaperPulmonary vaccine delivery has gained significant attention as an alternate route for vaccination without the use of needles. Immunization through the pulmonary route induces both mu...
Matching PubMed Articles
Treatment of asymptomatic pulmonary cryptococcosis in immunocompetent hosts with oral fluconazole.
Abstract Background: Pulmonary cryptococcosis is occasionally detected on routine imaging studies in healthy hosts with no or mild symptoms. Isolated pulmonary cryptococcosis may be observed without s...
Level of Evidence for Therapeutic Drug Monitoring of Fluconazole.
Fluconazole is a recommended treatment option for the treatment of invasive candidiasis. Fluconazole is active against most pathogenic Candida spp. except C. kruzei and C. glabrata. Fluconazole is ora...
Cystoid Macular Edema Secondary to Fluconazole Toxicity.
Fluconazole is an antifungal commonly used to treat Coccidioides immitis, but this medication has a number of side effects including fatigue, rash, headache, dizziness, nausea, vomiting, diarrhea, and...
Fluconazole resistance in cryptococcal disease: emerging or intrinsic?
With the widespread use of long-term fluconazole prophylaxis and suppressive treatment, the potential development of fluconazole resistance poses a threat to the management of cryptococcal disease. In...
Controlled pulmonary drug and gene delivery using polymeric nano-carriers.
Pulmonary drug and gene delivery to the lung represents a non-invasive avenue for local and systemic therapies. However, the respiratory tract provides substantial barriers that need to be overcome fo...
